Showing posts with label Diabetes:. Show all posts
Showing posts with label Diabetes:. Show all posts

Friday, July 27, 2012

Feces fossils show connection between Native-Americans, diabetes: Did fat-hoarding genes develop from the nature of ancient feasts?

ScienceDaily (July 24, 2012) — Why do Native Americans experience high rates of diabetes? A common theory is that they possess fat-hoarding "thrifty genes" left over from their ancestors -- genes that were required for survival during ancient cycles of feast and famine, but that now contribute to the disease in a modern world of more fatty and sugary diets.

See Also:Health & MedicineNutritionDiet and Weight LossCholesterolFossils & RuinsAncient CivilizationsArchaeologyFossilsReferenceDiabetic dietSouth Beach dietGlycemic indexMediterranean diet

A newly published analysis of fossilized feces from the American Southwest, however, suggests this "thrifty gene" may not have developed because of how often ancient Natives ate. Instead, researchers said, the connection may have come from precisely what they ate.

The research, which appears in the latest edition of the journal Current Anthropology, suggests that the prehistoric hunter-gatherer civilizations of the Southwest lived on a diet very high in fiber, very low in fat and dominated by foods extremely low on the glycemic index, a measure of effects food has on blood sugar levels. This diet, researchers said, could have been sufficient to give rise to the fat-storing "thrifty genes."

"What we're saying is we don't really need to look to feast or famine as a basis for (the genes)," said Karl Reinhard, professor of forensic sciences at the University of Nebraska-Lincoln's School of Natural Resources and the study's lead author. "The feast-or-famine scenario long hypothesized to be the pressure for 'thrifty genes' isn't necessary, given the dietary evidence we've found."

Natives have some of the highest rates of Type 2 diabetes of any group and are more than twice as likely to develop the disease as are Caucasians. The notion the gene's origin goes back to feast-and-famine cycles among prehistoric hunter-gatherer ancestors has been discussed for nearly a half-century.

To fully understand the basis of the high rates, Reinhard said, "one has to look at the best dietary data one can find. That comes from coprolites (the official term for fossilized feces). By looking at coprolites, we're seeing exactly what people ate."

The coprolites are from Antelope Cave, a deep cavern in northern Arizona where, over several thousands of years, was home to various cultures. That includes the Ancestral Pueblan peoples, who are believed to have lived there seasonally for at least 450 years.

Reinhard and Keith Johnson, an archeologist at California State University, Chico, studied 20 coprolites found in the cave and combined it with analysis from other sites for hints of ancient Natives' diets. They found clues to a food regimen dominated by maize and high-fiber seed from sunflowers, wild grasses, pigweed and amaranth. Prickly pear, a desert succulent, was also found repeatedly in the samples.

By volume, about three-quarters of the Antelope Cave coprolites were made up of insoluble fiber. The foods also were low on the glycemic index; some research suggests that high-GI foods may increase risk of obesity and diabetes.

The analysts' findings led them to deduce that the nature of the feast, and not necessarily its frequency, was enough to lock the "thrifty" genes in place -- and leave modern Natives more susceptible to diabetes as their diets evolved to lower-fiber, higher-GI foods.

"These were not just famine foods," the authors wrote. "These were the foods eaten on a day-by-day basis during all seasons in both feast and famine. They continued to be eaten even after agriculture was developed. Antelope Cave coprolites show that this high-fiber diet was eaten during the warmer seasons of food abundance."

In addition to UNL's Reinhard and California State Chico's Johnson, the study was authored by Isabel Teixeira-Santos and Monica Viera of the Escola Nacional de Saude Publica in Rio de Janeiro, Brazil.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:



View the Original article

Saturday, June 16, 2012

Diabetes: Tighter control of blood sugar prevents nerve condition, but at what risk?

ScienceDaily (June 13, 2012) — Aggressive control of blood sugar levels in diabetes can help to prevent a painful condition affecting patients' nerves, according to a new systematic review in The Cochrane Library. However, the review suggests that optimal target levels need to be established to prevent serious complications.

See Also:Health & MedicineDiabetesNeuropathyPersonalized MedicineHormone DisordersDiet and Weight LossBirth ControlReferenceBlood sugarDiabetic dietHyperglycemiaDiabetes mellitus type 2

People with diabetes control their blood sugar levels through insulin injections, diet and drugs, to compensate for their bodies producing too little insulin (type 1 diabetes) or becoming resistant to insulin (type 2 diabetes). Up to half of people with diabetes develop a disabling condition called diabetic neuropathy, which affects nerves in the feet and legs, making them feel tingly, numb, painful or weak. It is possible to prevent neuropathy by strict control of blood sugar levels through a number of ways including different insulin regimens and diet modification, but evidence for the effects of this approach, known as enhanced glucose control, has not been systematically reviewed until now.

The results analysed in the review are drawn from six studies investigating the risk of neuropathy in people who received enhanced glucose control treatments including extra insulin injections, antidiabetic drugs, and diet changes. The review looked at evidence in type 1 and type 2 diabetes separately. In two studies involving 1,228 people with type 1 diabetes significantly fewer people developed neuropathy each year with enhanced glucose control treatment compared with routine care. In four studies involving 6,669 people with type 2 diabetes the reduction in new cases of neuropathy was small and not statistically significant.

"Overall, this evidence suggests that a more aggressive approach to controlling sugar levels can be effective in delaying the onset of neuropathy in diabetes," said lead author of the review, Brian Callaghan, M.D., Assistant Professor in the Department of Neurology at the University of Michigan in Ann Arbor, Michigan, US. "The results also highlight the differences between type 1 and type 2 diabetes. The less dramatic effect of enhanced glucose control in type 2 diabetes may indicate that other factors, besides high glucose levels, may be important in causing nerve damage in these patients."

However, the risk of adverse effects associated with the treatment, including hypoglycaemia, was higher with enhanced glucose control. The researchers say further research is needed to optimise target levels for safe treatments that will both prevent neuropathy and minimise serious side effects.

"Although these results show clear benefits for preventing neuropathy in people with diabetes, they should be weighed against potential adverse effects," said Callaghan. "Future studies must establish target levels for glucose control that will balance benefits and side effects."

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:



View the Original article